How a Leftist Activist Group Helped Torpedo a Psychedelic Therapy (Gift Article) The fallout from the F.D.A.’s rejection of MDMA-assisted treatment for PTSD worries researchers and experts who fear other psychedelic drugs in the pipeline could be jeopardized.

People from both sides— #MAPS & #Psymposia— managed to slow down the progress of #psychedelicMedicine, maybe for good.
I agree with @neselsd.bsky.social that, with a #Left tag on the title, it is a "transparently partisan attack on behalf of a #pharmaceuticalCompany".
www.nytimes.com/2025/02/04/h...

#MAPS was certainly not forthcoming but neither is #psymposia #ethics. They don't have the high ground here.

I for one want full #decriminalization and not commercial selling for-profit so the #FDA is also wrong.

How a Leftist Activist Group Helped Torpedo a Psychedelic Therapy The fallout from the F.D.A.’s rejection of MDMA-assisted treatment for PTSD worries researchers and experts who fear other psychedelic drugs in the pipeline could be jeopardized.

www.nytimes.com/2025/02/04/h...
#psymposia more bullying - I hate bullies regardless of their alleged do-good agenda - these people sound malevolent. We need alternative therapies for trauma, and these people are fucking it up. #mdma #psychadelics

How an Activist Group Helped Torpedo MDMA Therapy

Hot off the press. Critical story of the psychedelic 'watchdogs'. #lykos #mdma #nyt #psymposia @psymposia @newyorktimes www.nytimes.com/2025/02/04/h...

The Unbelievable Claims of Psymposia about MAPS and MDMA-Assisted Therapy Geoff Bathje, initially supportive of Psymposia’s critiques within the psychedelic field, has grown skeptical of their recent approach. Bathje argues that Psymposia’s criticism of MAPS and Lykos lacks...

Well articulated. As an organization focused on practical #ethics, I found the critiques by #psymposia not credible using the guise of ethics. There is plenty to be critical about for sure, but this a good critique of their critique - chacruna.net/unbelievable.... interested in their response.